Mellor, Christopher https://orcid.org/0000-0001-9902-7040
James, Brandon T
Azad, Saeideh https://orcid.org/0009-0007-0496-1035
Kosmeder, Emma P
Purello, Chloe T
Singh, Monika
Simon, Victoria
Cheng, Nicholas W
Niedermaier, Jessica
Burgos-Barragan, Guillermo
Blenis, John O https://orcid.org/0000-0003-3622-2337
Mato, Anthony R
Field, Martha S https://orcid.org/0000-0001-7547-5180
Wang, Meng https://orcid.org/0000-0002-1573-0255
Funding for this research was provided by:
HHS | NIH | National Institute of General Medical Sciences (1R35GM160077-01)
St. Baldrick's Foundation (1278637)
American Association for Cancer Research (24-20-82)
Fanconi Cancer Foundation (24-20-82)
CU | College of Agriculture and Life Sciences, Cornell University (Start up fund)
CU | College of Veterinary Medicine, Cornell University (Center for Vertebrate Genomics Scholar Award)
Article History
Received: 23 March 2026
Revised: 26 July 2026
Accepted: 28 July 2026
First Online: 12 August 2026
Disclosure and competing interest statement
: A.R.M. is currently an employee of AstraZeneca; this work was conducted while A.R.M. was affiliated with Cayuga Cancer Center and is unrelated to his role at AstraZeneca. All other authors declare no conflicts of interest.